Collaboration Model
“SFJ remained committed to closing our deal, and worked within our company timeline for funding. SFJ demonstrated quick turn-around time during our contracting process, providing flexibility and creativity to meet our needs. The diligence process was timely, with demonstrated clinical expertise.”
— Mark Delong, SVP
Business Development and Strategy, Apellis Pharmaceuticals
SFJ provides the expertise, resources, operational implementation and at-risk funding to accelerate the late-stage clinical development of our Partners’ key pipeline assets.
- SFJ assumes 100% of the development & approval risk
- SFJ can execute studies at a global, regional, or country level, including China and Japan
- SFJ recognizes that each of our Pharma Partners has distinct needs and requirements. We listen to our Pharma Partners to thoroughly understand their specific operational challenges and then jointly construct a tailored co-development partnership
- We facilitate our partners’ focus on high-priority existing projects
- Our goal is to accelerate high-potential and time-sensitive projects that may otherwise be deferred due to resource limitations
- SFJ funding and resources also enable simultaneous major market development
Roles and Responsibilities
Typical Approach
An Alternative Approach
